Yumei Lai

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma.

A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma.

Journal: Nature communications

Published: August 08, 2025

Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial.

Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial.

Journal: Signal transduction and targeted therapy

Published: May 28, 2024

Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients.

Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: July 31, 2023

Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of 68Ga-FAPI PET/CT and 18F-FDG PET/CT.

Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of 68Ga-FAPI PET/CT and 18F-FDG PET/CT.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: January 30, 2023

PD-L1 immunohistochemistry assay optimization to provide more comprehensive pathological information in classic Hodgkin lymphoma.

PD-L1 immunohistochemistry assay optimization to provide more comprehensive pathological information in classic Hodgkin lymphoma.

Journal: Journal of hematopathology

Published: November 18, 2022

Different clinico-pathological and prognostic features of vulvar, vaginal, and cervical melanomas.

Different clinico-pathological and prognostic features of vulvar, vaginal, and cervical melanomas.

Journal: Human pathology

Published: May 15, 2022

Proliferation Marker Ki67 as a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal Melanoma.

Proliferation Marker Ki67 as a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal Melanoma.

Journal: Frontiers in oncology

Published: March 14, 2022

Different situations of identifying second primary malignant tumors in lymphoma patients with synchronous solid tumors.

Different situations of identifying second primary malignant tumors in lymphoma patients with synchronous solid tumors.

Journal: Cancer medicine

Published: December 02, 2021

Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas.

Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas.

Journal: Diagnostic pathology

Published: February 27, 2021

Detecting Fibroblast Activation Proteins in Lymphoma Using 68Ga-FAPI PET/CT.

Detecting Fibroblast Activation Proteins in Lymphoma Using 68Ga-FAPI PET/CT.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: February 15, 2021

Genetic alteration of Chinese patients with rectal mucosal melanoma.

Genetic alteration of Chinese patients with rectal mucosal melanoma.

Journal: BMC cancer

Published: January 14, 2021

Pyrotinib combined with CDK4/6 inhibitor in HER2-positive metastatic gastric cancer: A promising strategy from AVATAR mouse to patients.

Pyrotinib combined with CDK4/6 inhibitor in HER2-positive metastatic gastric cancer: A promising strategy from AVATAR mouse to patients.

Journal: Clinical and translational medicine

Published: June 01, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026